← Leaderboards
James F. Dawkins
Cedars-Sinai Medical Center
$3,591,824
Attributed
$3,591,824
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $730.6K · FY2017–25$1M$750K$500K$250K$0
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$3,591,824 · 2
By mechanism
R01$2,915,879 · 1
K01$675,945 · 1
Top collaborators
No co-investigators on record.
Most similar at Cedars-Sinai Medical Center
Same institution · by research overlap
- Hee Cheol Cho$8,819,637
- Eduardo Marban$26,448,338
- Piotr J Slomka$14,552,068
- Eugenio Cingolani$2,551,401
- Prediman Krishan Shah$8,075,140
Others in their field
Other Emerging Leaders on “Catheters”
- James N Campbell · Centrexion Therapeutics Corporation$8,662,635
- William Andrew Daunch · Focal Medical, Inc.$6,184,629
- Joshua B Gafford · Endotheia, Inc.$5,887,119
- Beverly Tang · Starlight Cardiovascular, Inc.$5,430,390
- Vasiliy Abramov · Creosalus, Inc.$4,531,717
- Thomas Diffley Pate · Alleviant Medical, Inc.$4,405,723
Research focus
CathetersVentricularIn VivoHeart FailurePreventSafetyChronicEvaluationAnimal ModelImplantMagnetic Resonance ImagingIon ChannelMapsPre-ClinicalArrhythmiaCellsCardiacClinicCardiac MyocytesCardiomyopathiesHeart FunctionFirst-In-HumanInjectionsPorcine Model
Grant awards (9)
Biological substrate modification to suppress ventricular arrhythmias in a porcine model of chronic ischemic cardiomyopathy$730,577
R01 · FY2025 · HL · contact PI
Biological substrate modification to suppress ventricular arrhythmias in a porcine model of chronic ischemic cardiomyopathy$724,148
R01 · FY2024 · HL · contact PI
Biological substrate modification to suppress ventricular arrhythmias in a porcine model of chronic ischemic cardiomyopathy$730,577
R01 · FY2023 · HL · contact PI
Biological substrate modification to suppress ventricular arrhythmias in a porcine model of chronic ischemic cardiomyopathy$730,577
R01 · FY2022 · HL · contact PI
Preclinical development of biological pacemakers$135,189
K01 · FY2021 · HL · contact PI
Preclinical development of biological pacemakers$135,189
K01 · FY2020 · HL · contact PI
Preclinical development of biological pacemakers$135,189
K01 · FY2019 · HL · contact PI
Preclinical development of biological pacemakers$135,189
K01 · FY2018 · HL · contact PI
Preclinical development of biological pacemakers$135,189
K01 · FY2017 · HL · contact PI